Clinical Trials Logo

Binge-Eating Disorder clinical trials

View clinical trials related to Binge-Eating Disorder.

Filter by:

NCT ID: NCT03784820 Completed - Clinical trials for Binge-Eating Disorder

Uniting Couples in the Treatment of Binge-Eating Disorder

UNITE
Start date: January 9, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to test the feasibility, acceptability, and preliminary effectiveness of a novel couple-based intervention for binge-eating disorder (BED) relative to an established evidence-based individual treatment (cognitive-behavioral therapy-enhanced; CBT-E) in a community clinic setting.

NCT ID: NCT03774433 Completed - Smoking Clinical Trials

Using Mobile Technology to Improve Self-Regulation

Start date: February 27, 2019
Phase: N/A
Study type: Interventional

This study will evaluate the degree to which engaging targets produces a desired change in medical regimen adherence (across 4-week interventions) and health behavior among smokers (n=50) and overweight/obese persons with binge eating disorder (n=50) (smoking in the former sample and binge eating in the latter sample). The investigators will employ a novel mobile behavioral assessment/intervention platform to engage targets in these samples, given that (1) it offers self-regulation assessment and behavior change tools via an integrated platform to a wide array of populations, and (2) content within the platform can be quickly modified as needed to better impact targets. This is the fourth and final phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes. This trial builds on NCT03352713.

NCT ID: NCT03717493 Completed - Clinical trials for Binge-Eating Disorder

Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder

ER-BED
Start date: December 17, 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The effectiveness of a systematic affect regulation training (ART; Berking, 2010) is evaluated with regard to reducing symptoms of binge eating disoder in a randomized controlled trial.

NCT ID: NCT03712748 Completed - Anorexia Nervosa Clinical Trials

Online Imaginal Exposure

Online IE
Start date: October 17, 2016
Phase: N/A
Study type: Interventional

This study evaluates if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety, and test an online format of IE to maximize its ability to reach as many individuals with eating disorders as possible. All participants will complete four imaginal exposure sessions and will complete questionnaires prior to receiving this treatment, as well as complete follow up questionnaires at 1-month, 6-month, and 12-month.

NCT ID: NCT03712462 Completed - Weight Loss Clinical Trials

Improving Weight Loss Outcomes for Binge Eating Disorder.

Start date: August 20, 2018
Phase: N/A
Study type: Interventional

This study aims to develop and evaluate the efficacy of a behavioral weight loss treatment approach for individuals with binge eating disorder to both reduce their binge eating behaviors and lose weight.

NCT ID: NCT03687658 Completed - Smoking Clinical Trials

Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating

Start date: September 12, 2019
Phase: N/A
Study type: Interventional

This study will evaluate the extent to which we can engage and manipulate putative targets within the self-regulation domain within and outside of laboratory settings in samples of smokers and overweight/obese individuals with binge eating disorder. This is the fourth phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.

NCT ID: NCT03680989 Completed - Eating Disorder Clinical Trials

A Pilot Test of Mood and Circadian Rhythm Mechanisms Driving Binge Eating

Start date: February 15, 2019
Phase: N/A
Study type: Interventional

Mood and circadian rhythm disruptions are associated with binge eating (BE). BE is a discrete, episodic behavior characterized by 1) eating an objectively large amount of food and 2) experiencing a subjective sense of loss of control. BE episodes are often preceded by negative mood states, and a subtype of individuals with BE has high levels of negative moods. This group has more comorbid psychopathology and a poorer response to treatment. Thus, understanding the role of negative mood is a critical area for research on BE. Individuals with BE demonstrate disruptions in several circadian rhythms, including diurnal meal timing, hormone patterns (e.g., daily cortisol rhythms), and mood variations. The most potent synchronizer of circadian rhythms is light. Thus, exposure to light may explain other phenomena that fluctuate similarly, such as mood and the occurrence of BE. Mood is subject to the influence of light, and BE is also influenced by exposure to bright light. It is unknown whether regulating circadian rhythms via regular exposure to light improves BE through its effects on mood or via changes in other biological or behavioral rhythms. This knowledge can inform the development of treatments targeting biobehavioral mechanisms that maintain BE and indicate for whom this may be most effective. This project aims to test the roles of negative mood and circadian rhythms in the relationship between light exposure and BE and identify subtypes of individuals in whom this effect is strong. The investigators hypothesize that individuals exposed to less natural bright light will experience more frequent BE, more negative mood, and a blunted morning cortisol response. The investigators further hypothesize that manipulating exposure to artificial bright light will reduce the frequency of BE and negative mood and increase the morning cortisol response. Finally, the investigators hypothesize that the effects of this artificial bright light exposure on BE frequency will be mediated by changes in negative mood, which itself will be accounted for by changes in circadian rhythms as indicated by the morning cortisol response. Additionally, the investigators have two moderation hypotheses: that the effects of artificial bright light exposure on BE will be greater for those who fit the high negative mood type than those who do not and that the effects will be greater for individuals with a blunted morning cortisol response at baseline than for those without.

NCT ID: NCT03678766 Completed - Obesity Clinical Trials

CHARGE: Controlling Hunger and ReGulating Eating

CHARGE
Start date: September 30, 2018
Phase: N/A
Study type: Interventional

The objectives of this proposed study are: 1) to evaluate feasibility and acceptability of a novel intervention, Regulation of Cues (ROC), and Cognitive Behavior Therapy (CBT), and 2) to evaluate the efficacy of both treatments on reduction of binge eating and weight loss among 120 Veterans with subclinical or clinical Binge Eating Disorder (BED) with comorbid overweight/obesity (OW/OB).

NCT ID: NCT03673540 Completed - Bulimia Nervosa Clinical Trials

Acquisition and Utilization of Skills Using Innovative Smartphone Application for Regular Eating

ACQUIRE
Start date: August 31, 2018
Phase: N/A
Study type: Interventional

The study seeks to evaluate the acceptability, feasibility, target engagement, and validity of an innovative smartphone application with ecological momentary interventions to augment cognitive behavioral therapy for bulimia nervosa.

NCT ID: NCT03604172 Completed - Clinical trials for Overweight and Obesity

Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder

Start date: August 8, 2018
Phase: N/A
Study type: Interventional

The purpose of this research is to conduct a randomized controlled trial (RCT) assessing the impact of CBT on neural responses to binge eating stimuli.